Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
4.890
-0.020 (-0.41%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $334.15 million as of April 29, 2025. Its market cap has decreased by -45.37% in one year.
Market Cap
334.15M
Enterprise Value
-98.51M
1-Year Change
-45.37%
Ranking
Category
Stock Price
$4.89
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $334.15M, a decrease of -81.38%. That is a compound annual growth rate of -31.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 335.52M | -21.98% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 776.76B |
| UnitedHealth Group | 379.57B |
| Johnson & Johnson | 373.09B |
| AbbVie | 337.41B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 224.32B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |